Testosterone Therapy's heart risks under the microscope for transgender youth
NCT ID NCT04977765
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how testosterone therapy changes heart and metabolic health in transgender boys and men aged 12 to 30. Researchers will measure blood vessel function, blood pressure, and body composition over one year. The goal is to understand any risks and whether starting therapy before or after puberty makes a difference.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSGENDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Study seeks to improve cancer screening for transgender individuals before hysterectomy
- Freezing hope: new study aims to protect fertility in transgender youth
- New study aims to freeze ovarian tissue for transgender fertility
- Hormone therapy's hidden impact on gut bugs and heart risk revealed in new study.
- New online tool aims to support Trans/Nonbinary young adults in love and life
- HIV PrEP and hormones: small study aims to Fine-Tune dosing for transgender women